- Home
- THFF vs ARCT Comparison
THFF vs ARCT Comparison
Compare THFF & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- ARCT
- Stock Information
- Founded
- THFF 1984
- ARCT 2013
- Country
- THFF United States
- ARCT United States
- Employees
- THFF N/A
- ARCT N/A
- Industry
- THFF Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- ARCT Health Care
- Exchange
- THFF Nasdaq
- ARCT Nasdaq
- Market Cap
- THFF 599.3M
- ARCT 487.0M
- IPO Year
- THFF N/A
- ARCT N/A
- Fundamental
- Price
- THFF $49.96
- ARCT $15.88
- Analyst Decision
- THFF Hold
- ARCT Strong Buy
- Analyst Count
- THFF 1
- ARCT 8
- Target Price
- THFF $45.00
- ARCT $61.00
- AVG Volume (30 Days)
- THFF 46.4K
- ARCT 405.9K
- Earning Date
- THFF 02-11-2025
- ARCT 03-06-2025
- Dividend Yield
- THFF 4.11%
- ARCT N/A
- EPS Growth
- THFF N/A
- ARCT N/A
- EPS
- THFF 4.00
- ARCT N/A
- Revenue
- THFF $201,592,000.00
- ARCT $160,399,000.00
- Revenue This Year
- THFF N/A
- ARCT $7.33
- Revenue Next Year
- THFF $11.39
- ARCT $4.71
- P/E Ratio
- THFF $12.41
- ARCT N/A
- Revenue Growth
- THFF N/A
- ARCT N/A
- 52 Week Low
- THFF $34.58
- ARCT $14.30
- 52 Week High
- THFF $51.87
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- THFF 56.31
- ARCT 41.74
- Support Level
- THFF $47.42
- ARCT $16.03
- Resistance Level
- THFF $49.23
- ARCT $17.95
- Average True Range (ATR)
- THFF 1.35
- ARCT 1.29
- MACD
- THFF 0.26
- ARCT -0.07
- Stochastic Oscillator
- THFF 75.81
- ARCT 10.29
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.